SARS-CoV-2 mRNA-based vaccines are about 95% effective in preventing COVID-19 1, 2, 3,
4, 5. The dynamics of antibody-secreting plasmablasts and germinal centre B cells …

We pursued a study of immune responses in coronavirus disease 2019 (COVID-19) and
influenza patients. Compared to patients with influenza, patients with COVID-19 exhibited …

SARS-CoV-2 mRNA vaccines induce robust anti-spike (S) antibody and CD4 + T cell
responses. It is not yet clear whether vaccine-induced follicular helper CD4 + T (T FH ) cell …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a pandemic
with millions of human infections. One limitation to the evaluation of potential therapies and …

Influenza viruses remain a major public health threat. Seasonal influenza vaccination in
humans primarily stimulates pre-existing memory B cells, which differentiate into a transient …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …

In this study we profiled vaccine-induced polyclonal antibodies as well as plasmablast-derived
mAbs from individuals who received SARS-CoV-2 spike mRNA vaccine. Polyclonal …

Germinal centres (GC) are lymphoid structures in which B cells acquire affinity-enhancing
somatic hypermutations (SHM), with surviving clones differentiating into memory B cells (MBCs…

Virus-induced interlukin-1β (IL-1β) and IL-18 production in macrophages are mediated via
caspase-1 pathway. Multiple microbial components, including viral RNA, are thought to …

Long-lived bone marrow plasma cells (BMPCs) are a persistent and essential source of
protective antibodies 1, 2, 3, 4, 5, 6, 7. Individuals who have recovered from COVID-19 have a …